1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-10.36%
Revenue decline while CSIQ shows 4.68% growth. Joel Greenblatt would examine competitive position erosion.
-3.80%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-33.63%
Gross profit decline while CSIQ shows 37.93% growth. Joel Greenblatt would examine competitive position.
-25.96%
Margin decline while CSIQ shows 31.77% expansion. Joel Greenblatt would examine competitive position.
53.13%
R&D growth above 1.5x CSIQ's 24.00%. Michael Burry would check for spending discipline.
-100.00%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
29.38%
Other expenses growth while CSIQ reduces costs. John Neff would investigate differences.
-10.96%
Operating expenses reduction while CSIQ shows 9.03% growth. Joel Greenblatt would examine advantage.
-5.04%
Total costs reduction while CSIQ shows 0.74% growth. Joel Greenblatt would examine advantage.
-16.56%
Both companies reducing interest expense. Martin Whitman would check industry trends.
10.99%
Similar D&A growth to CSIQ's 14.20%. Walter Schloss would investigate industry patterns.
-134.75%
EBITDA decline while CSIQ shows 31.41% growth. Joel Greenblatt would examine position.
-138.77%
EBITDA margin decline while CSIQ shows 25.53% growth. Joel Greenblatt would examine position.
-105.75%
Operating income decline while CSIQ shows 1654.05% growth. Joel Greenblatt would examine position.
-106.42%
Operating margin decline while CSIQ shows 1575.66% growth. Joel Greenblatt would examine position.
-113.09%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-112.68%
Pre-tax income decline while CSIQ shows 1862.98% growth. Joel Greenblatt would examine position.
-114.15%
Pre-tax margin decline while CSIQ shows 1775.25% growth. Joel Greenblatt would examine position.
-127.74%
Tax expense reduction while CSIQ shows 662.40% growth. Joel Greenblatt would examine advantage.
-111.73%
Net income decline while CSIQ shows 243.32% growth. Joel Greenblatt would examine position.
-113.09%
Net margin decline while CSIQ shows 227.97% growth. Joel Greenblatt would examine position.
-111.98%
EPS decline while CSIQ shows 245.45% growth. Joel Greenblatt would examine position.
-113.46%
Diluted EPS decline while CSIQ shows 227.27% growth. Joel Greenblatt would examine position.
0.55%
Share count reduction below 50% of CSIQ's 0.10%. Michael Burry would check for concerns.
-14.46%
Diluted share reduction while CSIQ shows 10.44% change. Joel Greenblatt would examine strategy.